Post by PressRelease on Feb 27, 2024 7:30am
New Press Release - Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA
Comment by
palinc2000 on Feb 27, 2024 7:53am
This is what Paul said 6 dsys ago during the CC Moreover, we are awaiting the PDUFA date for the sBLA submission of an intramuscular administration of the Trogarzo maintenance dose. These line extension efforts exemplify our commitment to innovate, further improve adherence, and simplify the treatment experience for people with HIV.
Comment by
Trogarzon on Feb 27, 2024 8:16am
And value creation coming up later this years... no thanks Paul. No Thanks...
Comment by
muslix1 on Feb 27, 2024 8:25am
the hope the have bonus this year for that 2 last NEWS
Comment by
palinc2000 on Feb 27, 2024 8:27am
While this is not as shattering on the operations as the CRL letter for F8 it adds to the string of defeats ..,If our friend Donald was in charge we know the 3 words he would be using . You are .....!!!
Comment by
Trogarzon on Feb 27, 2024 8:31am
Well you can do just that come May.... like I did for the past 3 years. Total sh t show. Unreal.
Comment by
Trogarzon on Feb 27, 2024 8:45am
In reality it's probably a good news in disguise. They probably would have waisted more money on the packaging and manufacturing and marketing on a drug that's not selling much and that would no have sold much more if so otherwhise. That being said why waste our money and time and create such a negative spin for that.. nothing.